Swiss drugmaker Roche said Friday that the Food and Drug Administration approved its drug Avastin as a treatment for ovarian cancer.
Roche said the FDA approved Avastin in combination with chemotherapy as a treatment for recurrent cases of cancer that are resistant to platinum-based chemotherapy.
Avastin is used to treat different types of colon cancer, lung cancer, glioblastoma, kidney cancer and cervical cancer.
Roche reported $6.25 billion in revenue from the drug in 2013.
